Coaching Tip
MARCH 15, 2011
Bottom line, the American economy is multi-faceted, robust and resilient. Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . Deregulation. Entrepreneurship.
Harvard Business Review
OCTOBER 25, 2018
These firms make up two thirds of global corporate pretax earnings (EBTDA) and revenues. We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Superstar firms create 1.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
SEPTEMBER 12, 2012
The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. At Harvard's Edmond J.
Harvard Business Review
NOVEMBER 30, 2017
A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. As a group, the largest U.S. In some instances, the end results were firm closures and lost jobs.
Harvard Business Review
SEPTEMBER 19, 2013
Thinking beyond the bottom line was considered unfocused or, even worse, a disservice to shareholders. Previously untapped markets drive financial returns. In these solution markets, businesses, social entrepreneurs, nonprofits, and multinational companies compete, coordinate, and collaborate to solve megaproblems.
Harvard Business Review
SEPTEMBER 13, 2016
The secret to changing an organization is to understand the fundamental units that make up the social system — these local tribes — and to invert the change process so that tribes own the change. A heavy manufacturing company was facing a downturn in its markets and the potential of sizable layoffs.
Harvard Business Review
JANUARY 31, 2013
First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines.
Expert insights. Personalized for you.
84 
Let's personalize your content